Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chronic Stress Accelerates Atherosclerosis Following Angioplasty Procedure

15.11.2005


Chronic stress can induce rapid blocking of arteries after a balloon angioplasty procedure, according to research performed in animal studies at Georgetown University Medical Center. Blocked coronary arteries after angioplasty affect 41 percent of patients who undergo the procedure and can lead to death.



But the Georgetown scientists also demonstrated that this stress-induced atherosclerosis could be prevented by blocking a certain neuropeptide in blood vessels. They say the results, published in the October issue of the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology, may someday lead to targeted therapy for individuals at risk for the condition.

The study is the newest in a series of animal studies that shows how chronic stress can be a high risk factor for accelerated atherosclerosis, a heart condition where plaque-like substances build up in the inner lining of an artery and can lead to heart attack or stroke. The study showed that the effects of stress were more rapid than the effects of a fat-rich diet in causing atherosclerosis.


“Stress is a newly emerging risk factor for cardiovascular disease but until now, we didn’t know the exact mechanism involved,” said Zofia Zukowska, MD, PhD, Professor of Physiology and Biophysics at Georgetown University Medical Center. “This research provides the first well-documented, experimental evidence in animals that stress can actually induce triggers that lead to vessel blockage and atherosclerosis.”

In the study, researchers performed an angioplasty procedure on two groups of rats, and then induced stress in the experimental group. Follow-up tests carried out after just two weeks of daily stress showed that this stress significantly increased blood pressure and doubled circulating levels of neuropeptide Y (NPY) compared to rats that did not undergo stress. NPY is a neurotransmitter present in the nerves surrounding blood vessels which become activated by stress. Stress-activated nerves then release NPY onto the cells within the vessel wall, where it exerts several potent actions.

Previously, researchers knew that NPY could cause acute narrowing of the vessel by contraction of its muscular wall. However, this study showed that it has even more profound effects when it its levels are elevated chronically. In stressed rats which underwent angioplasty, NPY stimulated growth of abnormal smooth muscle in the blood vessels and caused them to become blocked with lesions containing microphages, thrombus and lipid deposits. These lesions resembled plaques which develop in humans in a process of atherosclerosis and are the cause of vessel blocking after angioplasty. This process has never before been reproduced in normal laboratory animals, unless they were genetically manipulated or were fed a fat-rich diet.

Researchers also found that it was possible to reverse this process by giving rats a compound that prevented cells from reading the increased levels of NPY. This compound, called the Y1 receptor antagonist, completely prevented the NPY-induced changes, allowing rats to undergo stress without increasing risk for atherosclerosis.

“This research has great potential for clinical applications in the future,” said Zukowska. “Although this needs more study, if this same phenomenon occurs in humans, it is possible that Y1 antagonist could be used as a therapy for at-risk individuals.”

Zukowska noted that if validated in humans, the research could be particularly applicable to men, whose bodies release more NPY during stress and who are generally more susceptible to heart attacks than pre-menopausal women. The findings also may prove helpful for individuals with mutations in the NPY gene, which occurs in some ethnic populations in as high as 9 percent of people, and which causes nerves to release the neurotransmitter in elevated levels.

Other co-authors on the paper include Lijun Li, PhD, and Ken Abe, MS, from Georgetown University and Anne-Catherine Jonsson-Rylander, PhD of AstraZeneca, Sweden, the company which provided Y1 receptor antagonist.

About BGRO

Georgetown’s Biomedical Graduate Research Organization (BGRO) was created to foster cutting-edge, interdisciplinary collaboration and to enhance the university’s research capacity, especially in the areas of child and human health and development, the neurosciences, cardiovascular-kidney health, and in shared work with researchers and clinicians from Georgetown’s Lombardi Comprehensive Cancer Center. BGRO is also focused on educational and academic excellence in the biomedical sciences in order to train the next generation of scientific researchers in the United States and around the world.

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through our partnership with MedStar Health). Our mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis—or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, and the world-renowned Lombardi Comprehensive Cancer Center.

Liz McDonald | EurekAlert!
Further information:
http://www.georgetown.edu

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>